Takeda Pharmaceutical Company Limited ( NYSE: TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ET Christopher O’Reilly - Head, Investor Relations Christophe Weber - President and Chief ...
High levels of glucose, albumin, ascorbic acid, tetracycline or cephalexin, or large amounts of oxalic acid, may inhibit the reaction and lead to false-negative results. Vaginal contamination can ...
1 Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland 2 Infectious Diseases Service, University of ...